Relmada Therapeutics
RLMD
RLMD
82 hedge funds and large institutions have $335M invested in Relmada Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.4% less ownership
Funds ownership: 57.33% → 56.93% (-0.4%)
27% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 26
Holders
82
Holding in Top 10
2
Calls
$17M
Puts
$1.15M
Top Buyers
| 1 | +$10.2M | |
| 2 | +$6.51M | |
| 3 | +$5.88M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.92M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.75M |
Top Sellers
| 1 | -$8.57M | |
| 2 | -$3.96M | |
| 3 | -$3.85M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.09M |
| 5 |
Aviva
London,
United Kingdom
|
-$1.08M |